Skip to main content
# Title Research Year
71 Development of the Use of Amorphous Silicon (ASi) Electronic Portal Imaging Devices as a Physics Tool for Routine Linear Accelerator QA 2016
72 Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy 2016
73 Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy 2016
74 Evaluation of the efficacy and the safety of a hypofractionated
radiotherapy course with weekly concomitant boost for breast
cancer patients treated with conservative breast surgery
2016
75 Evaluation of the efficacy and the safety of a hypofractionated
radiotherapy course with weekly concomitant boost for breast
cancer patients treated with conservative breast surgery
2016
76 Excision Repair Cross-Complementation Group 1 (ERCC1): A Prognostic and Predictive Biomarker in Patients with Colorectal Cancer Receiving Adjuvant Oxaliplatin Based Chemotherapy 2016
77 Hypofractionation versus conventional radiotherapy
with concurrent Gemcitabine in bladder preservation of
patient with bladder carcinoma
2016
78 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. 2016
79 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. 2016
80 Multimodality Treatment for Pediatric Nasopharyngeal Carcinoma: A Review of 24 patients in Upper Egypt. 2016